(3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D004874:Ergonovine / Q000494:pharmacology; D004947:Esophagus / Q000294:innervation; D005724:Ganglia / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D009433:Neural Inhibition / Q000187:drug effects*; D011955:Receptors, Drug / Q000187:drug effects*; D012908:Snails
D002395:Catecholamines; D007093:Imidazoles; D011955:Receptors, Drug; D003000:Clonidine; D004298:Dopamine; D004874:Ergonovine